The Independent Uganda: You get the Truth we Pay the Price
Berlin, Germany | Xinhua | German biotechnology company BioNTech and U.S. company Pfizer have started clinical trials of an Omicron-based COVID-19 vaccine candidate in healthy adults 18 through 55 years of age, the companies said on Tuesday. The trials would evaluate the safety, tolerability and immunogenicity of the vaccine candidate, according …
Read More »Pfizer, BioNTech start clinical trial of Omicron-specific COVID-19 vaccine
